Article
FDA grants accelerated approval to olaratumab for soft tissue sarcoma
Olaratumab, a platelet-derived growth factor receptor-alpha blocking antibody, is the first new therapy approved in 40 years for the initial...
Article
Uninsured rate lowest in Massachusetts
Massachusetts had the nation’s lowest uninsured rate in 2015, and Texas had the highest
Article
Picking at a Problem
Article
Ozanimod has lasting effect on ulcerative colitis
LAS VEGAS – Ozanimod has a lasting effect on symptoms of ulcerative colitis, according to results from an open-label study presented at the annual...
Article
Experts: Fewer opioids, more treatment laws mean nothing without better access to care
Pressure on physicians to prescribe fewer opioids could have unintended consequences in the absence of adequate access to treatment
Article
SAVR for radiation-induced aortic stenosis has high late mortality
ROME – Mortality is high following surgical aortic valve replacement in patients with radiation-induced severe aortic stenosis, and STS score is...
Article
Frailty stratifies pediatric liver disease severity
The pediatric frailty score identified patients with end-stage liver disease with sensitivity of 47% and specificity of 98%.
Article
High resting heart rate may signal exacerbation risk in COPD patients
Higher resting heart rate may predict future risk of exacerbation in patients with recent COPD exacerbation, results from a multicenter study...
News
What to Know about CMS’s New Emergency Preparedness Requirements
The Centers for Medicare & Medicaid Services recently released new emergency preparedness requirements to ensure that providers and suppliers...
News
EBV-CTLs accepted into EMA’s PRIME program
among uninfected cells (blue) Image courtesy of Benjamin Chaigne-Delalande The European Medicines Agency (EMA) has accepted into its Priority...